A Double-Masked, Randomized, Single-Center Study Evaluating the Effect of 0.30% Ketorolac/0.80% HPMC, 0.80% HPMC and Vehicle on Symptoms of Dry Eye After Exposure to the Controlled Adverse Environment (CAE)

NCT03693183 Phase 2 WITHDRAWN

The purpose of this study is to determine whether ketorolac and Hydroxypropyl Methylcellulose are effective in the treatment of Dry Eye.

Details

Lead sponsor	ORA, Inc.
Phase	Phase 2
Status	WITHDRAWN
Start date	2009-03
Completion	2009-06-15

Conditions

• Dry Eye

Interventions

• Ketorolac/HPMC
• HPMC
• Vehicle

Primary outcomes

• Efficacy of Ketorolac and HPMC on ocular discomfort using the Ora Calibra® Ocular Discomfort scale. — Day 0 through Day 9
  Evaluate the symptoms of Ketorolac and HPMC on ocular discomfort in subjects with dry eye syndrome.

Countries

United States